Golgi Targeting and Retention of Yeast Kex2 Protease
酵母 Kex2 蛋白酶的高尔基体靶向和保留
基本信息
- 批准号:7458655
- 负责人:
- 金额:$ 28.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-05-01 至 2010-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcanthocytosisAntibodiesBiochemicalBiochemical GeneticsBiogenesisBiological AssayCell membraneCellsChoreaClathrinClathrin AdaptorsClathrin-Coated VesiclesCoated vesicleCohen syndromeDataDefectDiseaseEmployee StrikesEndopeptidasesEnzymesEventExhibitsGenesGoalsGolgi TargetingGrantHereditary DiseaseHomologous GeneHumanIntegral Membrane ProteinLocalizedMeasuresMembraneMembrane Transport ProteinsMolecularMutationNerve DegenerationNeurodevelopmental DisorderPathway interactionsPeptide HydrolasesProcessProteinsPublishingReactionRecruitment ActivityRecyclingRegulationRoleSiteSorting - Cell MovementSystemTranscription Factor AP-1Transport VesiclesVacuolar Protein SortingVesicleWorkYeastsbaseintracellular protein transportlate endosomeprotein localization locationreceptorreconstitutiontemperature sensitive mutanttrans-Golgi Network
项目摘要
DESCRIPTION (provided by applicant): Steady-state localization of transmembrane proteins of the trans Golgi network (TGN) is achieved by dynamic recycling between TGN and endosomal compartments. These transport pathways localize processing enzymes (e.g. Kex2 protease and furin) to their sites of action, effect lysosomal/vacuolar biogenesis and regulate levels of plasma membrane transporters and receptors. The fundamental importance of these pathways is underscored by their evolutionary conservation. The need to define TGN-endosomal transport pathways biochemically led us in the last grant period to begin to develop rapid, quantitative assays for cell-free reconstitution of these transport pathways. In this grant period, we will specifically focus on vesicular transport from the TGN to the late endosome, a key pathway both in lysosomal biogenesis and in processing protein localization that has not been reconstituted in any other system. Our overall goals will be to define mechanisms of vesicle budding, cargo sorting and regulation and vesicle scission in the formation of the clathrin coated vesicles that function in this step. Strong preliminary data, both published and unpublished, form the basis for the proposed work. The Specific Aims of this proposal are: 1. To determine rigorously whether there is a clathrin-coated vesicle intermediate in the reaction, to purify and characterize this intermediate and determine its molecular composition and to devise a vesicle budding assay that provides a direct assay for cargo recruitment. 2. To elucidate the roles of Gga1/2p versus AP1 adaptors in vesicle formation and cargo selection and determine how they are recruited to membranes. 3. To determine how cargo proteins are recruited to TGN-PVC transport vesicles and how they interact with adaptors or other components of the vesicle coat.
描述(由申请人提供):反式高尔基网络(TGN)跨膜蛋白的稳态定位是通过TGN和内体室之间的动态循环来实现的。这些转运途径将加工酶(如Kex2蛋白酶和furin)定位到它们的作用位点,影响溶酶体/液泡生物发生,并调节质膜转运蛋白和受体的水平。这些途径的基本重要性被它们的进化守恒所强调。由于需要从生物化学角度定义tgn -内体运输途径,我们在上一个资助期开始开发快速、定量的方法来检测这些运输途径的无细胞重建。在此资助期内,我们将特别关注从TGN到晚期内体的囊泡运输,这是溶酶体生物发生和加工蛋白质定位的关键途径,在任何其他系统中都没有重建。我们的总体目标将是确定在这一步骤中起作用的网格蛋白包被囊泡形成过程中的囊泡出芽、货物分类和调节以及囊泡分裂的机制。已发表和未发表的强有力的初步数据构成了拟议工作的基础。本建议的具体目标是:1。严格确定反应中是否存在网格蛋白包覆的囊泡中间体,对该中间体进行纯化和表征,确定其分子组成,并设计囊泡出芽试验,为货物招募提供直接试验。2. 阐明Gga1/2p与AP1接头在囊泡形成和货物选择中的作用,并确定它们如何被招募到膜上。3. 确定货物蛋白如何被招募到TGN-PVC运输囊泡中,以及它们如何与适配器或囊泡外壳的其他成分相互作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERTA S. FULLER其他文献
ROBERTA S. FULLER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERTA S. FULLER', 18)}}的其他基金
Nikon TiE Motorized Microscope System For 3D Image Acquisition, Deconvolution, Li
Nikon TiE 电动显微镜系统,用于 3D 图像采集、反卷积、Li
- 批准号:
7794471 - 财政年份:2010
- 资助金额:
$ 28.35万 - 项目类别:
GORDON CONFERENCE:HORMONAL & NEURAL PEPTIDE BIOSYNTHESIS
戈登会议:荷尔蒙
- 批准号:
6159568 - 财政年份:2000
- 资助金额:
$ 28.35万 - 项目类别:
GOLGI TARGETING AND RETENTION OF YEAST KEX2 PROTEASE
酵母 KEX2 蛋白酶的高尔基体靶向和保留
- 批准号:
2189110 - 财政年份:1994
- 资助金额:
$ 28.35万 - 项目类别:
Golgi Targeting and Retention of Yeast Kex2 Protease
酵母 Kex2 蛋白酶的高尔基体靶向和保留
- 批准号:
7637257 - 财政年份:1994
- 资助金额:
$ 28.35万 - 项目类别:
GOLGI TARGETING AND RETENTION OF YEAST KEX2 PROTEASE
酵母 KEX2 蛋白酶的高尔基体靶向和保留
- 批准号:
6180456 - 财政年份:1994
- 资助金额:
$ 28.35万 - 项目类别:
GOLGI TARGETING AND RETENTION OF YEAST KEX2 PROTEASE
酵母 KEX2 蛋白酶的高尔基体靶向和保留
- 批准号:
3309658 - 财政年份:1994
- 资助金额:
$ 28.35万 - 项目类别:
GOLGI TARGETING AND RETENTION OF YEAST KEX2 PROTEASE
酵母 KEX2 蛋白酶的高尔基体靶向和保留
- 批准号:
2189111 - 财政年份:1994
- 资助金额:
$ 28.35万 - 项目类别:
GOLGI TARGETING AND RETENTION OF YEAST KEX2 PROTEASE
酵母 KEX2 蛋白酶的高尔基体靶向和保留
- 批准号:
2415243 - 财政年份:1994
- 资助金额:
$ 28.35万 - 项目类别:
GOLGI TARGETING AND RETENTION OF YEAST KEX2 PROTEASE
酵母 KEX2 蛋白酶的高尔基体靶向和保留
- 批准号:
2189112 - 财政年份:1994
- 资助金额:
$ 28.35万 - 项目类别:
Golgi Targeting and Retention of Yeast Kex2 Protease
酵母 Kex2 蛋白酶的高尔基体靶向和保留
- 批准号:
7240476 - 财政年份:1994
- 资助金额:
$ 28.35万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 28.35万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 28.35万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 28.35万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 28.35万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 28.35万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 28.35万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 28.35万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 28.35万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 28.35万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 28.35万 - 项目类别:














{{item.name}}会员




